Search research articles
Contact Us
Filters
Showing results (41-50 of 82) with videos related to
Page
of 9
Sort By:
The Journal of Investigative Dermatology
|
July 1, 2006
Rab33A: characterization, expression, and suppression by epigenetic modification
Elaine Cheng, Sergio E Trombetta, Daniela Kovacs, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 19, 2012
Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate
Byung Hak Ha, Matthew J Davis, Catherine Chen, et al.
Nature Communications
|
July 13, 2016
Germline MC1R status influences somatic mutation burden in melanoma
Carla Daniela Robles-Espinoza, Nicola D Roberts, Shuyang Chen, et al.
Genome Research
|
August 26, 2016
A generic, cost-effective, and scalable cell lineage analysis platform
Tamir Biezuner, Adam Spiro, Ofir Raz, et al.
The Journal of Clinical Investigation
|
January 9, 2018
Early B cell changes predict autoimmunity following combination immune checkpoint blockade
Rituparna Das, Noffar Bar, Michelle Ferreira, et al.
American Journal of Human Genetics
|
August 2, 2016
GNA14 Somatic Mutation Causes Congenital and Sporadic Vascular Tumors by MAPK Activation
Young H Lim, Antonella Bacchiocchi, Jingyao Qiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2006
Expression of tumor necrosis factor--related apoptosis-inducing ligand receptors 1 and 2 in melanoma
Mary M McCarthy, Kyle A DiVito, Mario Sznol, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2024
Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma
David G Su, David A Schoenfeld, Wael Ibrahim, et al.
Pigment Cell & Melanoma Research
|
November 29, 2013
Identification of PLX4032-resistance mechanisms and implications for novel RAF inhibitors
Jaehyuk Choi, Sean F Landrette, Tiffany Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2014
PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
Lucia B Jilaveanu, Fabio Parisi, Meaghan L Barr, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 82) with videos related to
Sort By:
Page
of 9
The Journal of Investigative Dermatology
|
July 1, 2006
Rab33A: characterization, expression, and suppression by epigenetic modification
Elaine Cheng, Sergio E Trombetta, Daniela Kovacs, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 19, 2012
Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate
Byung Hak Ha, Matthew J Davis, Catherine Chen, et al.
Nature Communications
|
July 13, 2016
Germline MC1R status influences somatic mutation burden in melanoma
Carla Daniela Robles-Espinoza, Nicola D Roberts, Shuyang Chen, et al.
Genome Research
|
August 26, 2016
A generic, cost-effective, and scalable cell lineage analysis platform
Tamir Biezuner, Adam Spiro, Ofir Raz, et al.
The Journal of Clinical Investigation
|
January 9, 2018
Early B cell changes predict autoimmunity following combination immune checkpoint blockade
Rituparna Das, Noffar Bar, Michelle Ferreira, et al.
American Journal of Human Genetics
|
August 2, 2016
GNA14 Somatic Mutation Causes Congenital and Sporadic Vascular Tumors by MAPK Activation
Young H Lim, Antonella Bacchiocchi, Jingyao Qiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 2006
Expression of tumor necrosis factor--related apoptosis-inducing ligand receptors 1 and 2 in melanoma
Mary M McCarthy, Kyle A DiVito, Mario Sznol, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2024
Digital spatial proteomic profiling reveals immune checkpoints as biomarkers in lymphoid aggregates and tumor microenvironment of desmoplastic melanoma
David G Su, David A Schoenfeld, Wael Ibrahim, et al.
Pigment Cell & Melanoma Research
|
November 29, 2013
Identification of PLX4032-resistance mechanisms and implications for novel RAF inhibitors
Jaehyuk Choi, Sean F Landrette, Tiffany Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 16, 2014
PLEKHA5 as a Biomarker and Potential Mediator of Melanoma Brain Metastasis
Lucia B Jilaveanu, Fabio Parisi, Meaghan L Barr, et al.
Page
of 9